We are live on
!
Find out more
PCM
Palouse Capital Management Portfolio holdings
AUM
$160M
1-Year Est. Return
36.15%
This Fund
S&P 500
This Quarter
Est. Return
+0.14%
1 Year Est. Return
+36.15%
3 Year Est. Return
+67.75%
5 Year Est. Return
+68.17%
10 Year Est. Return
+160.38%
AUM
$295M
AUM Growth
-$5.07M
(-1.7%)
Cap. Flow
-$4.85M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
24.99%
Holding
111
New
10
Increased
45
Reduced
43
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$3.94M |
| 2 |
US Bancorp
USB
|
+$3.69M |
| 3 |
Citizens Financial Group
CFG
|
+$2.16M |
| 4 |
Bank of America
BAC
|
+$1.46M |
| 5 |
AT&T
T
|
+$1.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Campbell Soup
CPB
|
+$6.54M |
| 2 |
Aptiv
APTV
|
+$3.4M |
| 3 |
Occidental Petroleum
OXY
|
+$3.11M |
| 4 |
JNPR
Juniper Networks
JNPR
|
+$1.97M |
| 5 |
Macy's
M
|
+$1.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.41% |
| 2 | Financials | 15.31% |
| 3 | Technology | 14.04% |
| 4 | Industrials | 10.81% |
| 5 | Consumer Discretionary | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Prudential Financial
PRU
$42.7B
| $8.44M | 2.86% |
90,274
+1,991
| +2% | +$201K |
|
2
Pfizer
PFE
$143B
| $8.31M | 2.82% |
241,538
-5,102
| -2% | -$174K |
|
3
Wells Fargo
WFC
$266B
| $8.02M | 2.72% |
144,669
+4,990
| +4% | +$267K |
|
4
BP
BP
$114B
| $7.71M | 2.61% |
179,385
-9,783
| -5% | -$411K |
|
5
Nucor
NUE
$59.5B
| $7.46M | 2.53% |
119,332
-3,195
| -3% | -$204K |
|
|
IPG
6
DELISTED
Interpublic Group of Companies
IPG
| $7.33M | 2.48% |
312,823
-5,730
| -2% | -$135K |
|
7
Microsoft
MSFT
$3.62T
| $6.86M | 2.32% |
69,530
-3,242
| -4% | -$314K |
|
8
J.M. Smucker
SJM
$12.6B
| $6.59M | 2.23% |
61,304
+4,081
| +7% | +$458K |
|
9
Huntington Bancshares
HBAN
$35.1B
| $6.57M | 2.22% |
444,856
-9,738
| -2% | -$146K |
|
10
Gilead Sciences
GILD
$163B
| $6.52M | 2.21% |
92,042
-1,331
| -1% | -$94K |
|
|
11
AT&T
T
$162B
| $6.42M | 2.17% |
264,823
+51,960
| +24% | +$1.3M |
|
12
Intel
INTC
$459B
| $6.38M | 2.16% |
128,265
-1,459
| -1% | -$77.5K |
|
13
Eaton
ETN
$170B
| $6.34M | 2.15% |
84,773
-1,297
| -2% | -$100K |
|
14
KLA
KLAC
$239B
| $6.33M | 2.14% |
617,460
-13,580
| -2% | -$148K |
|
15
Amgen
AMGN
$204B
| $6.25M | 2.12% |
33,865
-441
| -1% | -$78K |
|
16
Johnson Controls International
JCI
$88.7B
| $6.19M | 2.1% |
185,112
-1,336
| -0.7% | -$46.4K |
|
17
AbbVie
ABBV
$433B
| $6.1M | 2.07% |
65,856
-903
| -1% | -$88.2K |
|
18
Procter & Gamble
PG
$338B
| $5.92M | 2% |
75,827
+13,014
| +21% | +$979K |
|
19
International Paper
IP
$21.9B
| $5.91M | 2% |
119,765
+1,663
| +1% | +$85K |
|
20
Cisco
CSCO
$457B
| $5.91M | 2% |
137,230
+7,464
| +6% | +$326K |
|
21
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $5.63M | 1.9% |
149,182
+384
| +0.3% | +$14.3K |
|
22
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.6B
| $5.51M | 1.87% |
70,591
+82
| +0.1% | +$6.41K |
|
23
CVS Health
CVS
$134B
| $5.42M | 1.84% |
84,251
+1,913
| +2% | +$126K |
|
24
MetLife
MET
$62B
| $5.16M | 1.75% |
118,285
-713
| -0.6% | -$33.2K |
|
25
Apple
AAPL
$4.46T
| $4.87M | 1.65% |
105,236
-3,984
| -4% | -$181K |
|
Similar funds
MWM
PCC
CF
SGCM
RCWM
LCA
WHCI
FPWM
Palouse Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Palouse Capital Management held 111 positions worth $295M, down 1.7% from $300M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Palouse Capital Management's Q2 2018 filing shows 10 new, 45 increased, 43 reduced and 9 closed positions. Its largest new stake was Johnson & Johnson: 31,547 shares worth $3.83M. The largest sale was Campbell Soup, an estimated $6.54M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
- Palouse Capital Management's largest Q2 2018 buy was Johnson & Johnson: 31,547 shares worth $3.83M.
- Palouse Capital Management added most to Bank of America in Q2 2018, an estimated $1.46M increase.
- Palouse Capital Management's biggest Q2 2018 reduction was Aptiv, cutting an estimated $3.4M.
- Palouse Capital Management fully exited Campbell Soup in Q2 2018, selling an estimated $6.54M.
- Palouse Capital Management's ten largest holdings make up 25% of its $295M portfolio in Q2 2018.
- Palouse Capital Management opened 10 new positions and closed 9 in Q2 2018.
- Palouse Capital Management's portfolio value fell 1.7% quarter-over-quarter to $295M.
Based on Palouse Capital Management's 13F filing for Q2 2018, filed 27 Jul 2018.